Page last updated: 2024-10-29

ketamine and Myalgia

ketamine has been researched along with Myalgia in 1 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Myalgia: Painful sensation in the muscles.

Research Excerpts

ExcerptRelevanceReference
"Ketamine seems to be an attractive alternative due to its rapid-onset antidepressant effects and impact on suicidal thoughts."3.01Efficacy and adverse effects of ketamine versus electroconvulsive therapy for major depressive disorder: A systematic review and meta-analysis. ( Cavalcanti, S; de A Simoes Moreira, D; Fonseca da Silva, AC; Gauer, LE; Quevedo, J; Teixeira, G, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
de A Simoes Moreira, D1
Gauer, LE1
Teixeira, G1
Fonseca da Silva, AC1
Cavalcanti, S1
Quevedo, J1

Reviews

1 review available for ketamine and Myalgia

ArticleYear
Efficacy and adverse effects of ketamine versus electroconvulsive therapy for major depressive disorder: A systematic review and meta-analysis.
    Journal of affective disorders, 2023, 06-01, Volume: 330

    Topics: Antidepressive Agents; Depressive Disorder, Major; Electroconvulsive Therapy; Humans; Ketamine; Myal

2023